These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 34101138)
1. Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial. Tambiah JRS; Kennedy S; Swearingen CJ; Simsek I; Yazici Y; Farr J; Conaghan PG Rheumatol Ther; 2021 Jun; 8(2):973-985. PubMed ID: 34101138 [TBL] [Abstract][Full Text] [Related]
2. A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Lattermann C; Skrepnik N; Swearingen CJ; Simsek I; Ghandehari H; DiFrancesco A; Gibbs J; Tambiah JRS; Hochberg MC Osteoarthritis Cartilage; 2021 May; 29(5):654-666. PubMed ID: 33588087 [TBL] [Abstract][Full Text] [Related]
3. Comparing Patient-Reported Outcomes From Sham and Saline-Based Placebo Injections for Knee Osteoarthritis: Data From a Randomized Clinical Trial of Lorecivivint. Tambiah JRS; Simsek I; Swearingen CJ; Kennedy S; Cole BJ; McAlindon TE; Yazici Y Am J Sports Med; 2022 Mar; 50(3):630-636. PubMed ID: 35005990 [TBL] [Abstract][Full Text] [Related]
4. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial. Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388 [TBL] [Abstract][Full Text] [Related]
5. Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study. Fineman MS; McAlindon TE; Lattermann C; Swearingen CJ; Kennedy S; Lopez VA; Simsek I; Tambiah JRS; Yazici Y Rheumatol Ther; 2023 Dec; 10(6):1741-1752. PubMed ID: 37902943 [TBL] [Abstract][Full Text] [Related]
6. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales. Ross E; Katz NP; Conaghan PG; Kivitz A; Turk DC; Spitzer AI; Jones DG; Lanier RK; Cinar A; Lufkin J; Kelley SD Pain Ther; 2022 Mar; 11(1):289-302. PubMed ID: 34791634 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study. Krupka E; Jiang GL; Jan C Osteoarthritis Cartilage; 2019 Nov; 27(11):1599-1607. PubMed ID: 31351965 [TBL] [Abstract][Full Text] [Related]
8. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. Yazici Y; McAlindon TE; Fleischmann R; Gibofsky A; Lane NE; Kivitz AJ; Skrepnik N; Armas E; Swearingen CJ; DiFrancesco A; Tambiah JRS; Hood J; Hochberg MC Osteoarthritis Cartilage; 2017 Oct; 25(10):1598-1606. PubMed ID: 28711582 [TBL] [Abstract][Full Text] [Related]
9. A novel diclofenac gel (AMZ001) applied once or twice daily in subjects with painful knee osteoarthritis: A randomized, placebo-controlled clinical trial. Bihlet AR; Byrjalsen I; Simon LS; Carrara D; Delpy L; Derne C Semin Arthritis Rheum; 2020 Dec; 50(6):1203-1213. PubMed ID: 33059293 [TBL] [Abstract][Full Text] [Related]
10. Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained? Berenbaum F; Langford R; Perrot S; Miki K; Blanco FJ; Yamabe T; Isogawa N; Junor R; Carey W; Viktrup L; West CR; Brown MT; Verburg KM Eur J Pain; 2021 Aug; 25(7):1525-1539. PubMed ID: 33728717 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline. Brander V; Skrepnik N; Petrella RJ; Jiang GL; Accomando B; Vardanyan A Osteoarthritis Cartilage; 2019 Jan; 27(1):59-70. PubMed ID: 30223023 [TBL] [Abstract][Full Text] [Related]
12. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment. Deshmukh V; O'Green AL; Bossard C; Seo T; Lamangan L; Ibanez M; Ghias A; Lai C; Do L; Cho S; Cahiwat J; Chiu K; Pedraza M; Anderson S; Harris R; Dellamary L; Kc S; Barroga C; Melchior B; Tam B; Kennedy S; Tambiah J; Hood J; Yazici Y Osteoarthritis Cartilage; 2019 Sep; 27(9):1347-1360. PubMed ID: 31132406 [TBL] [Abstract][Full Text] [Related]
13. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Bellamy N; Campbell J; Robinson V; Gee T; Bourne R; Wells G Cochrane Database Syst Rev; 2005 Apr; (2):CD005328. PubMed ID: 15846755 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis. Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336 [TBL] [Abstract][Full Text] [Related]
15. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Kivitz A; Ma C; Ahdieh H; Galer BS Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450 [TBL] [Abstract][Full Text] [Related]
16. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial. Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100 [TBL] [Abstract][Full Text] [Related]
17. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G; Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804 [TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies. Saltzman BM; Leroux T; Meyer MA; Basques BA; Chahal J; Bach BR; Yanke AB; Cole BJ Am J Sports Med; 2017 Sep; 45(11):2647-2653. PubMed ID: 28027657 [TBL] [Abstract][Full Text] [Related]
19. Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis. Conrozier T; Eymard F; Chouk M; Chevalier X BMC Musculoskelet Disord; 2019 Aug; 20(1):376. PubMed ID: 31421686 [TBL] [Abstract][Full Text] [Related]